Smead Capital Management Has Trimmed Its Stake in Johnson & Johnson (JNJ) as Stock Value Rose; Great Point Partners Holding in Vanda Pharmaceuticals (VNDA) Decreased by $29.49 Million as Share Price Declined

February 15, 2018 - By Nellie Frank

Smead Capital Management Inc decreased its stake in Johnson & Johnson (JNJ) by 1.35% based on its latest 2017Q3 regulatory filing with the SEC. Smead Capital Management Inc sold 4,280 shares as the company’s stock rose 6.85% with the market. The institutional investor held 313,615 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $40.77M, down from 317,895 at the end of the previous reported quarter. Smead Capital Management Inc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $348.39B market cap company. The stock increased 0.01% or $0.01 during the last trading session, reaching $129.68. About 1.36M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since February 15, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Jeffrey Jay decreased its stake in Vanda Pharmaceuticals Inc (VNDA) by 77.71% based on its latest 2017Q3 regulatory filing with the SEC. Great Point Partners Llc sold 1.73M shares as the company’s stock declined 5.00% while stock markets rallied. The hedge fund run by Jeffrey Jay held 497,531 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $8.91 million, down from 2.23M at the end of the previous reported quarter. Great Point Partners Llc who had been investing in Vanda Pharmaceuticals Inc for a number of months, seems to be less bullish one the $750.29M market cap company. The stock increased 5.36% or $0.85 during the last trading session, reaching $16.7. About 132,327 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 51.60% since February 15, 2017 and is uptrending. It has outperformed by 34.90% the S&P500.

Since January 2, 2018, it had 0 insider buys, and 4 sales for $3.36 million activity. Birznieks Gunther also sold $130,777 worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Tuesday, January 2. $140,494 worth of stock was sold by Kelly James Patrick on Tuesday, January 2. 10,367 shares were sold by Gulino Richard L., worth $157,565.

Among 8 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 22 analyst reports since September 2, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Monday, June 26. The company was maintained on Wednesday, March 9 by JMP Securities. JMP Securities maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Friday, August 26 with “Market Outperform” rating. On Thursday, August 3 the stock rating was maintained by Piper Jaffray with “Buy”. On Monday, October 30 the stock rating was maintained by Oppenheimer with “Outperform”. The rating was maintained by Jefferies on Tuesday, February 13 with “Buy”. Piper Jaffray maintained the shares of VNDA in report on Wednesday, September 2 with “Buy” rating. Jefferies maintained the stock with “Buy” rating in Monday, September 4 report. On Thursday, August 3 the stock rating was maintained by Oppenheimer with “Buy”. As per Monday, January 8, the company rating was maintained by Oppenheimer.

Investors sentiment increased to 1.43 in 2017 Q3. Its up 0.26, from 1.17 in 2017Q2. It increased, as 12 investors sold VNDA shares while 34 reduced holdings. 21 funds opened positions while 45 raised stakes. 38.89 million shares or 4.39% more from 37.25 million shares in 2017Q2 were reported. 51,321 were reported by Rhumbline Advisers. Meeder Asset Mngmt Inc accumulated 2,952 shares or 0.01% of the stock. Bancshares Of New York Mellon has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Us National Bank De reported 0% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Federated Investors Pa invested in 0% or 25,131 shares. Capital One Association reported 18,890 shares. Orbimed Llc holds 967,859 shares or 0.17% of its portfolio. Dekabank Deutsche Girozentrale owns 11,100 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 1,527 shares in its portfolio. Cortina Asset Limited Liability Company invested 0.16% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). 20,118 are held by Voya Investment Management Llc. Cheyne Cap (Uk) Llp stated it has 24,000 shares. Credit Suisse Ag owns 53,676 shares or 0% of their US portfolio. D E Shaw And stated it has 0.01% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Jpmorgan Chase & holds 0% or 59,338 shares in its portfolio.

Great Point Partners Llc, which manages about $935.83M and $514.03M US Long portfolio, upped its stake in Ptc Therapeutics Inc (NASDAQ:PTCT) by 840,000 shares to 1.10M shares, valued at $22.01M in 2017Q3, according to the filing. It also increased its holding in Sage Therapeutics Inc (NASDAQ:SAGE) by 57,900 shares in the quarter, for a total of 109,500 shares, and has risen its stake in Global Blood Therapeutics In.

Analysts await Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to report earnings on February, 21. They expect $-0.12 earnings per share, down 400.00% or $0.16 from last year’s $0.04 per share. After $-0.10 actual earnings per share reported by Vanda Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 20.00% negative EPS growth.

Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It is without change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Regent Investment Mgmt Ltd Liability Co accumulated 46,786 shares. Associated Banc, a Alabama-based fund reported 196,798 shares. Moreover, Webster Bancorp N A has 1.48% invested in Johnson & Johnson (NYSE:JNJ) for 78,268 shares. Sva Plumb Wealth Mngmt Lc reported 1.59% of its portfolio in Johnson & Johnson (NYSE:JNJ). Buckingham Capital Mngmt owns 1.7% invested in Johnson & Johnson (NYSE:JNJ) for 59,174 shares. Geller Family Office Serv Ltd Liability Com, a New York-based fund reported 28,269 shares. Trustmark National Bank & Trust Tru Department, a Mississippi-based fund reported 46,243 shares. Hightower Advisors Limited Liability Company owns 1.24M shares. 6.81 million are held by Dimensional Fund Limited Partnership. Van Cleef Asset Managementinc holds 2.78% or 78,520 shares in its portfolio. Nuveen Asset Lc invested 0.28% of its portfolio in Johnson & Johnson (NYSE:JNJ). Parametrica Management Ltd reported 0.22% in Johnson & Johnson (NYSE:JNJ). Coho Prtnrs Limited stated it has 647,338 shares or 2.16% of all its holdings. Wells Fargo Co Mn stated it has 0.97% of its portfolio in Johnson & Johnson (NYSE:JNJ). 278,951 are held by Barrett Asset Mngmt Ltd Liability Corp.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>